Histone deacetylase inhibitors: Are they here to stay?
Ibrahim
Rami B
RB
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D018572:Disease-Free Survival; D056572:Histone Deacetylase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077337:Vorinostat
D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat